Hyperfine, Inc. (NASDAQ:HYPR - Get Free Report) shares traded up 1.5% on Thursday . The company traded as high as $1.02 and last traded at $1.01. 62,037 shares changed hands during trading, a decline of 38% from the average session volume of 100,791 shares. The stock had previously closed at $1.00.
Hyperfine Stock Performance
The company has a 50-day moving average of $0.97 and a 200-day moving average of $1.00. The stock has a market capitalization of $72.95 million, a price-to-earnings ratio of -1.75 and a beta of 0.86.
Hyperfine (NASDAQ:HYPR - Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.14) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.14). The company had revenue of $3.64 million during the quarter, compared to analysts' expectations of $3.40 million. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. During the same period in the previous year, the firm posted ($0.15) earnings per share. As a group, analysts expect that Hyperfine, Inc. will post -0.57 earnings per share for the current year.
Institutional Investors Weigh In On Hyperfine
An institutional investor recently raised its position in Hyperfine stock. Geode Capital Management LLC lifted its position in shares of Hyperfine, Inc. (NASDAQ:HYPR - Free Report) by 18.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 624,520 shares of the company's stock after buying an additional 98,335 shares during the period. Geode Capital Management LLC owned 0.86% of Hyperfine worth $675,000 as of its most recent SEC filing. Institutional investors own 15.03% of the company's stock.
About Hyperfine
(
Get Free Report)
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Featured Articles
Before you consider Hyperfine, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperfine wasn't on the list.
While Hyperfine currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
